Camilla Sylvest
Director/Board Member at ARGENX SE
Net worth: 84 396 $ as of 2024-04-29
Profile
Ms. Camilla Sylvest is an Independent Non-Executive Director at argenx SE, an EVP-Commercial Strategy & Corporate Affairs at Novo Nordisk A/S, an Independent Director at Danish Crown A/S and a Senior Vice President & General Manager-Germany at Novo Nordisk Pharma GmbH.
She is on the Board of Directors at argenx SE, Danish Crown A/S and World Diabetes Foundation.
She received her graduate degree from the University of Southern Denmark and an MBA from Scandinavian International Management Institute.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ARGEN-X SE
0.00% | 2024-02-19 | 225 ( 0.00% ) | 84 396 $ | 2024-04-29 |
Camilla Sylvest active positions
Companies | Position | Start |
---|---|---|
NOVO NORDISK A/S | Corporate Officer/Principal | 2002-12-31 |
ARGENX SE | Director/Board Member | 2022-09-07 |
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Corporate Officer/Principal | 2011-10-17 |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Director/Board Member | - |
World Diabetes Foundation | Director/Board Member | - |
Training of Camilla Sylvest
Scandinavian International Management Institute | Masters Business Admin |
University of Southern Denmark | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
NOVO NORDISK A/S | Health Technology |
ARGENX SE | Health Technology |
Private companies | 3 |
---|---|
Novo Nordisk Pharma GmbH
Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Health Technology |
Danish Crown A/S
Danish Crown A/S Food: Meat/Fish/DairyConsumer Non-Durables Danish Crown A/S wholesales and distributes meat and meat products. It operates pig and beef slaughterhouses. The firm's products include luncheon meat and sausages to hamburgers, schnitzels, and ready-made dishes for the retail trade and large scale kitchens and restaurant industry. The company was founded in 1887 and is headquartered in Randers, Denmark | Consumer Non-Durables |
World Diabetes Foundation | Miscellaneous |
- Stock Market
- Insiders
- Camilla Sylvest